legislation: 102-hr-6178
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102-hr-6178 | 102 | hr | 6178 | Antiprogestin Testing Act of 1992 | Health | 1992-10-05 | 1992-11-20 | Referred to the Subcommittee on Health and the Environment. | House | Rep. Wyden, Ron [D-OR-3] | OR | D | W000779 | 2 | Antiprogestin Testing Act of 1992 - Directs the Secretary of Health and Human Services to conduct and support research, including clinical trials, on antiprogestin drug safety and efficacy for any potential use, including termination of pregnancy, contraception, and therapeutic use for cancer, endocrine disorders, and endometriosis. Makes the research subject to provisions relating to institutional review boards and peer review. | 2025-08-26T15:15:38Z |